KnowTheStock
Log inCreate free account

IQVIA Holdings Inc

IQV
S&P 500Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · NEW YORK STOCK EXCHANGE INC.
$193.28last close · market cap 32.34 Billion
Compare with…
37.3SCORE / 100
Our verdictSELLWeak Growth, Stock Price Very HighQtr Ending 2026-06-30 · trend negative

Why Sell

Income statement and cash flow are moderate; balance sheet is weak.

Next earnings: 2026-10-27 (BMO), EPS Forecast: $2.94

What is strong
  • Net Income Growth is 11.16%
  • Earnings Per Share (EPS) Growth is 17.49%
What to watch
  • Revenue Growth is 8.17%
  • Operating Income Growth is 1.01%
  • Net Margin is 8.1%
  • Current Asset to Current Liability Ratio is 0.71
  • Debt Ratio is 0.79
  • Current Debt to Net Income Ratio is 8.96
  • Total Debt to Total Assets Ratio is 0.54
  • Cash from Operations Growth is 7.72%
  • Capital Expenditure is High
  • Net Increase in Cash is Negative
  • Investment Risk is High

What changed

Score by quarter

Downgraded from Hold to Sell in the Mar 2025 quarter: 48.1 → 39.3 (-8.9). This quarter: +0.6.

304050Sep 2022Jun 2026

What the score is made of

Income statement55.1 +1.9
Balance sheet2.0 -4.2
Cash flow41.0 +5.1

Change vs previous quarter.

Key numbers · latest quarter

Revenue (TTM)16.98 Billion8.17 % growth
EPS8.0617.49 % growth
Profit margin8.10 %Profit per $1 of sales
P-E ratio—Not available
Market cap32.34 BillionShares × price
Debt-equity ratio2.61Leverage
Dividend0.00Per share, annual
Next earnings2026-10-27BMO · EPS forecast $2.94
Better viewed in landscape mode.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.

About IQVIA Holdings Inc

quintiles and imshealth have merged together to form the new quintilesims. each wanting to bring something new to customers, we deliver integrated information and technology solutions to drive healthcare forward. quintilesims has approximately 50,000 employees conducting operations in more than 100 countries, dedicated to helping our clients improve their clinical, scientific and commercial results. as a global leader in protecting individual patient privacy, quintilesims uses healthcare data to deliver critical, real-world disease and treatment insights. to learn more, visit www.quintilesims.com

CEO
Ari Bousbib
Employees
67,893
Sector
Professional, Scientific, and Technical Services
Exchange
NEW YORK STOCK EXCHANGE INC.
ir.iqvia.com

Similar stocks

Loading…